First‐in‐human study with ACT‐1014‐6470, a novel oral complement factor 5a receptor 1 (C5aR1) antagonist, supported by pharmacokinetic predictions from animals to patients
Article in Basic & Clinical Pharmacology & Toxicology (June 2022)
The most recent citing publications are shown below. View all 64 publications that cite this research output on Dimensions.
Article in Basic & Clinical Pharmacology & Toxicology (June 2022)
Article in European Journal of Pharmaceutical Sciences (July 2020)
Article in Clinical Pharmacology Advances and Applications (July 2020)